Kejin Biotechnology

About:

Kejin Biotechnology develops high-end laboratory consumables and underlying novel materials that are monopolized by imports.

Top Investors: Addor Capital, Industrial Securities Capital, Sinopharm-CICC

Description:

Kejin Biotechnology performs research and development of high-end laboratory consumables and membrane products for liquid treatment, molecular biology, cell preservation, and culture, which are based on innovative materials monopolized by imports.

Total Funding Amount:

100M CNY

Headquarters Location:

Zhangjiang, Shanghai, China

Founded Date:

Founders:

Number of Employees:

Last Funding Date:

2023-05-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai